Sourav Ghosh

Sourav Ghosh

Auto-generated profile, based on publicly available information

Sourav Ghosh

Department of Pharmaceutical Technology, School of Health & Medical Sciences, Adamas University, Barasat, Kolkata, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Heliyon
Verified
Journal Article
Open access
SGSourav Ghosh
Sourav Ghosh
AKArvind Kumar
Arvind Kumar
NSNeetu Sachan
Neetu Sachan
PCPhool Chandra
Phool Chandra
In this study, the anxiolytic activity of Piper nigrum essential oil (PNEO) was evaluated in the elevated plus maze (EPM) and the antidepressant-like effect was evaluated through tail suspension test (TST) in mice. Flumazenil, a competitive inhibitor of GABAA receptor in the benzodiazepine site and WAY-100635 maleate salt, a 5-HT1A receptor antagonist were used to find out the possible mechanism(s) of action of PNEO. To exclude the false-positive results due to the enhancement of the locomotor activity, the animals were submitted to open field test (OFT). We also measured monoamines levels of the mice brain after acute PNEO treatment. The data obtained from the study suggest that the anxiolytics and antidepressant-like effect of PNEO have observed in EPM and TST respectively in a dose-dependent manner after oral acute and repetitive treatment. WAY-100635, but not flumazenil was able to reverse the effect of PNEO in EPM and TST both, indicating the possible involvement of 5-HT1A receptor. The neurochemical analysis showed no alteration in monoamine levels in mice brains. Furthermore, no locomotor impairment or sign of toxicity or changes in body weight or abnormalities in the biochemical parameters, except for a significant decrease in total cholesterol level was observed after treatment with PNEO. The findings suggest that Piper nigrum EO possesses a dual anxiolytic and antidepressant-like effect through the possible involvement of serotonergic transmission.

1 August 2025 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
SDSrabona Dutta
Srabona Dutta
SGSourav Ghosh
Sourav Ghosh
Monosiz RahamanMonosiz Rahaman
Monosiz Rahaman
SCSejuti Ray Chowdhary
Sejuti Ray Chowdhary
Small extracellular vesicles called exosomes, which cells release, have drawn a lot of attention recently because of their ability to serve as therapeutic delivery systems for drugs and regenerative medicine applications. The investigation of plant-based exosomes as a cutting-edge platform for drug administration has emerged as an enticing research topic. A summary of the pharmaceutical feasibility of exosomes generated from plants and their uses in drug delivery along with regenerative medicine are the goals of this review study. Plant exosomes can be combined into nanoparticlebased medication delivery systems to increase their stability, targeting, and cargo delivery capabilities. By loading plant exosomes with therapeutic compounds and encapsulating them within nanoparticles, controlled release and targeted distribution to specific cells or tissues may be achieved. In gene therapy, plant exosomes can be modified to carry nucleic acids like plasmid DNA, siRNA, or miRNA. Effective gene delivery and therapeutic gene expression regulation can be accomplished by encasing nucleic acids in exosomes or surface-modifying exosomes to improve their interaction with target cells. In this review, we through the history and features of plant exosomes, examine how they differ from mammalian exosomes, and consider how they may be used for gene therapy, tissue regeneration, and targeted medication delivery. The difficulties and prospects for creating exosomebased plant medicines are also explored.

11 February 2025 in Zeitschrift für Naturforschung C
Verified
Journal Article
Closed access
BBBiswajit Basu
Biswajit Basu
Monosiz RahamanMonosiz Rahaman
Monosiz Rahaman
SGSourav Ghosh
Sourav Ghosh
SDSwarnali Dutta
Swarnali Dutta
Ashwini KumarAshwini Kumar
Ashwini Kumar
Sudarshan SinghSudarshan Singh
Sudarshan Singh
Sericin, a protein extracted from the cocoons of silkworms, has recently become an attractive biomaterial due to its potential as a good candidate for wound healing especially wounds seen in diabetic and immune-compromised patients. This review discusses the special biological nature of sericin such as its water-solubility and inherent moisturizing properties, antimicrobial, and antioxidant activities, which can act synergistically to foster ideal conditions for wound healing. The incorporation of sericin into composite wound dressings along with other natural and synthetic polymers was found to improve the mechanical properties, biocompatibility, and overall therapeutic performance. Moreover, the review draws attention toward sericin-based materials in diabetic wound healing with a focus on promoting rapid tissue regeneration and cell proliferation and enhancing clinical outcomes that conventional therapeutics cannot serve. The review also discusses the challenges associated with the production and application of sericin-based wound dressings and outlines the prospects for this emerging field. As research continues to advance, silk sericin holds the potential to revolutionize wound care, offering innovative solutions for the effective and holistic management of complex wounds.

1 January 2011 in International Journal of Green Pharmacy
Verified
Journal Article
Closed access
AKArvind Kumar
Arvind Kumar
SGSourav Ghosh
Sourav Ghosh
VSVaishali Singh
Vaishali Singh

30 December 2011 in Biomedical and Pharmacology Journal
Verified
Journal Article
Closed access
AKArvind Kumar
Arvind Kumar
SGSourav Ghosh
Sourav Ghosh
VVVaishali Vaishali
Vaishali Vaishali

3 May 2026 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
Himanshu SharmaHimanshu Sharma
Himanshu Sharma
STSachin Tyagi
Sachin Tyagi
SVSuryakant Verma
Suryakant Verma
SGSourav Ghosh
Sourav Ghosh
MPMilind Sharad Pande
Milind Sharad Pande